For: | Chen JF, Wu ZQ, Liu HS, Yan S, Wang YX, Xing M, Song XQ, Ding SY. Cumulative effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease in China. World J Gastroenterol 2024; 30(10): 1346-1357 [PMID: 38596503 DOI: 10.3748/wjg.v30.i10.1346] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i10/1346.htm |
Number | Citing Articles |
1 |
Di Wang, Bing-Yan Zhou, Lei Xiang, Xu-Yong Chen, Jie-Xiong Feng. Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease. World Journal of Gastroenterology 2024; 30(25): 3132-3139 doi: 10.3748/wjg.v30.i25.3132
|
2 |
Amedeo Lonardo. Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology: Long life to the old biomarker!. World Journal of Gastroenterology 2024; 30(24): 3016-3021 doi: 10.3748/wjg.v30.i24.3016
|
3 |
Chen-Xiao Huang, Xiao-Dong Zhou, Calvin Q Pan, Ming-Hua Zheng. Screening for metabolic dysfunction-associated fatty liver disease: Time to discard the emperor’s clothes of normal liver enzymes?. World Journal of Gastroenterology 2024; 30(22): 2839-2842 doi: 10.3748/wjg.v30.i22.2839
|